Skip to main content

Month: August 2024

Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer

NORCROSS, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D., an accomplished senior executive with expertise in liver disease to Chief Medical Officer effective immediately. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said “We are very excited to elevate Dr. Jamil to Chief Medical Officer. After joining us in March 2024 as Vice President Clinical Development and Medical Director, Khurram has quickly integrated himself into our team and has led the management of our NAVIGATE clinical trial of belapectin. Khurram is well known in the hepatology community and has over 20 years of experience. After completing his general surgery residency at Seton...

Continue reading

Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024

SANTA MONICA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), a leader in redefining the gaming industry as a media channel, announced today that the Company will post its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link. Super League Second Quarter 2024 Earnings WebinarDate: Wednesday, August 14, 2024Time: 5:00 pm Eastern TimeDial-in: 1-877-407-0779International Dial-in: 1-201-389-0914Webinar: Register Here   A replay will be available shortly after the webinar ends and can be accessed here or on the Company’s investor relations website at https://ir.superleague.com/. About Super...

Continue reading

BlockQuarry Corp. Unveils Strategic Shift Towards AI and HPC Integration for Enhanced Growth and Efficiency

HOUSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) — via IBN – BlockQuarry Corp. (OTC: BLQC), a leading Texas-based energy and infrastructure company, is thrilled to announce a significant strategic shift from Bitcoin mining to AI-driven data storage and high-performance computing (HPC). This transition aims to reduce operating costs, boost revenue, and maximize return on investment (ROI). The AI market is on a meteoric rise, projected to reach $190.61 billion by 2025. BlockQuarry is poised to leverage this explosive growth by pivoting to AI-driven data storage and HPC, thus optimizing operational efficiency and reducing energy consumption. The HPC market, set to reach $109.99 billion by 2032, offers immense opportunities driven by advances in computing power and demand across multiple sectors. “Our strategic shift towards AI and HPC is a...

Continue reading

Accredited Solutions to Meet With Outside Advisors Over the Weekend to Finalize Decision on Potential Reverse Stock Split

NEW YORK, NY, Aug. 01, 2024 (GLOBE NEWSWIRE) — Accredited Solutions, Inc. (OTC: ASII) (“Accredited Solutions” or the “Company”), the parent company of Diamond Creek Water, an ionized alkaline bottled water distributed in major grocery and convenience store chains, is considering a reverse stock split of its issued common stock. The company will be having a series of zoom meetings with outside financial and legal advisors over the course of the weekend to make a final decision over the option to execute a resolution to authorize and put into effect, a 500-to-1 reverse stock split. Sincerely,Eduardo Brito, CEO Relevant Links: https://www.diamondcreekwater.com Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not...

Continue reading

ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires

LOS ANGELES, Aug. 01, 2024 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM), a leader in innovative wound care solutions, proudly announces the successful completion of pivotal distribution agreements across the Middle East and Eastern Europe. Dr. Christopher Otiko, President of ViaDerma, recently returned from the United Arab Emirates, where he met with representatives from two leading distribution companies in Dubai and finalized agreements centered around ViaDerma’s flagship topical antibiotic product. These agreements are designed to significantly expand the company’s global market presence. The partner companies, known for their expertise in supplying wholesale products to private enterprises and government entities, will play a crucial role in enhancing the availability of Vitastem in these strategically important...

Continue reading

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

SAN MATEO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointments of two biotechnology industry leaders, Anne Phillips and Jennifer Jarrett, to the board of directors of the Company, effective August 1, 2024. “We are thrilled to welcome Anne and Jennifer to our board as we prepare to start our Phase 3 clinical development of denifanstat in MASH this year,” said Dave Happel, CEO of Sagimet. “Their expertise will be critical as we advance denifanstat into late-stage development. With her deep experience in clinical, medical, and regulatory affairs and service on the boards of both numerous companies and...

Continue reading

Ocean Power Technologies Announces Patent Pending on Innovative Docking and Recharging Buoy Technology

MONROE TOWNSHIP, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced the filing of a patent pending for its groundbreaking docking and recharging buoy technology, specifically designed for the Wave Adaptive Modular Vessel (WAM-V) Unmanned Surface Vehicle (USV). This advanced system has already been successfully demonstrated, showcasing its potential to revolutionize the operational efficiency of autonomous marine vessels. The patent-pending docking and recharging buoy technology represents a significant step forward in the capabilities of USVs, offering a reliable solution for extended missions and operations in remote ocean environments. This technology...

Continue reading

Aqua Metals to Announce Second Quarter 2024 Financial Results and Host Investor Conference Call on August 5, 2024

RENO, Nev., Aug. 01, 2024 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced it will report financial results for the second quarter ended June 30, 2024, and provide a business update after the market closes on Monday, August 5, 2024. Following the release, management will host a conference call that same day at 4:30 p.m. ET. The live conference call can be accessed at https://event.webcasts.com/aqms or from the investor relations section of the Company’s website at https://ir.aquametals.com/. Alternatively, interested parties can access the audio call by dialing 877-407-9708 (toll-free) or 201-689-8259 (international). Following the conclusion of the live event, a replay will be available by dialing 877-660-6853 (toll-free) or 201-612-7415 (international)...

Continue reading

Standard Lithium Announces Leadership Transition for Strategic Growth and Next Steps in Value Creation

Positioning Standard Lithium for Next Phase of Corporate Growth VANCOUVER, British Columbia, Aug. 01, 2024 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today announced a leadership transition that aligns with the Company’s growth strategy and next steps in value creation. Effective September 1, 2024, Robert Mintak will retire as Chief Executive Officer and remain engaged as an advisor through August 2025. David Park will assume the position of Chief Executive Officer effective September 1, 2024. Over the past year, David Park has been actively engaged with Standard Lithium as a strategic advisor, working closely with the senior management team. His deep understanding of the Company’s vision...

Continue reading

Vericel Reports Second Quarter 2024 Financial Results

Total Revenue of $52.7 Million, with MACI Revenue Growth of 21% to $44.1 Million NexoBrid Revenue Growth of 76% Over Prior Quarter Gross Margin of 70% and Adjusted EBITDA Growth of 42% Full-Year Profitability Guidance Raised to 71% Gross Margin and 21% Adjusted EBITDA Margin Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the second quarter ended June 30, 2024. Second Quarter 2024 Financial HighlightsTotal net revenue of $52.7 million MACI® net revenue growth of 21% to $44.1 million Burn Care net revenue of $8.5 million, consisting of $7.8 million of Epicel® revenue and $0.8 million of NexoBrid® revenue Gross...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.